Search results
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript February 15, 2024...
Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability
Simply Wall St. via Yahoo Finance· 4 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Investors in Alnylam Pharmaceuticals (NASDAQ:ALNY) have seen strong returns of 121% over the past...
Simply Wall St. via Yahoo Finance· 7 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shareholders might be concerned after seeing the share...
Alnylam Pharmaceuticals First Quarter 2023 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 year agoAlnylam Pharmaceuticals (NASDAQ:ALNY) First Quarter 2023 Results Key Financial Results Revenue:...
Alnylam Pharmaceuticals Inc (ALNY) Reports 35% YoY Growth in Q3 2023 Net Product Revenues
GuruFocus.com via Yahoo Finance· 7 months agoAlnylam Pharmaceuticals Inc (NASDAQ:ALNY) reported Q3 2023 global net product revenues of $313...
Should You Buy Alnylam Pharmaceuticals (ALNY) Ahead of Earnings?
Zacks via Yahoo Finance· 1 year agoAlnylam Pharmaceuticals (ALNY) is seeing favorable earnings estimate revision activity and has a...
Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 weeks agoAlnylam Pharmaceuticals Inc (NASDAQ:ALNY) showcases robust revenue growth with a 54.8% increase in...
Why Alnylam Pharmaceuticals Stock Is Vaulting Higher Today
Motley Fool· 2 years agoShares of Alnylam Pharmaceuticals (NASDAQ: ALNY) are poised to post a new all-time high upon market...
Why Alnylam Pharmaceuticals Topped the Market Today
Motley Fool· 10 months agoWhat happened The fight against Alzheimer's disease seems to be advancing, and one biotech developing a treatment for the degenerative brain disorder...
Alnylam (ALNY) Q1 Earnings Beat, Product Sales Drive Revenues
Zacks via Yahoo Finance· 1 year agoAlnylam Pharmaceuticals (ALNY) reports better-than-expected first-quarter 2023 results. Givlaari,...